A multi-center phase II study of Doxil/carboplatin in patients with advanced or recurrent endometrial carcinoma
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2013
At a glance
- Drugs Carboplatin (Primary) ; Doxorubicin liposomal (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 28 Sep 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 06 Jun 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.
- 11 Jul 2007 New trial record.